Peer Review

IJBT uses independent peer review by transfusion medicine specialists and methodologists. Reviewers evaluate study design, reporting clarity, and clinical relevance.

Ethics and Consent

Human studies must include IRB approval and informed consent. Donor and recipient privacy must be protected, and ethical approvals should be reported clearly.

Conflicts of Interest

Authors, editors, and reviewers must disclose financial or professional relationships that could influence interpretation. Transparency supports trust in transfusion findings.

Research Integrity

IJBT screens for plagiarism and data integrity concerns. We follow COPE guidance for corrections, retractions, and expressions of concern when needed.

Clinical Impact and Publishing Value

IJBT prioritizes blood safety, clinical relevance, and transparent reporting for transfusion medicine research.

Clinical Trial Registration

Clinical trials should be registered in a recognized registry with the registration number included in the manuscript.

Data Availability

Data availability statements are required to support reproducibility and responsible reuse of transfusion data.

Corrections and Retractions

If errors are identified after publication, IJBT issues corrections or retractions to maintain the integrity of the record.

Plagiarism and Misconduct

Manuscripts are screened for plagiarism and data manipulation. Suspected misconduct is handled according to COPE guidelines and may result in rejection or retraction.

Authorship Ethics

Authorship should reflect substantial contributions to the work. Guest, gift, or ghost authorship is not permitted.

Appeals and Complaints

Authors may appeal editorial decisions with supporting evidence. Complaints are reviewed by the editorial office and, when needed, by independent advisors.

Human and Animal Research

Human studies require IRB approval and informed consent. Animal studies must follow institutional guidelines and relevant ethical regulations.

Clinical Trial Disclosure

Trials should be registered in recognized registries prior to enrollment. Registration identifiers must be included in the manuscript.

Data and Materials Availability

Authors must provide data availability statements and describe how materials can be accessed. Clear access terms support reproducibility and responsible reuse.

Confidentiality

Editors and reviewers must treat manuscripts as confidential and may not use unpublished data for personal or institutional advantage or external collaborations strictly.

Reviewer Conduct

Reviewers are expected to provide constructive, respectful feedback and disclose conflicts. Reviews should focus on scientific merit and clinical relevance.

Funding Transparency

All funding sources and sponsor roles must be disclosed. Transparency helps readers assess potential influences on transfusion research findings for clinical trials.

Image and Data Integrity

Image manipulation that alters results is prohibited. The journal may request original data or images to resolve concerns.

Post Publication Queries

Questions about published articles are reviewed promptly. Authors may be asked to provide clarifications or additional documentation.

Editorial Oversight

The editorial board monitors policy compliance and updates guidance as standards evolve in transfusion medicine. This ensures consistent handling of complex clinical and laboratory studies.

Corrections Timeline

When corrections are required, IJBT aims to publish updates promptly to minimize misinformation. Transparency protects clinical decision making and patient safety.

Clinical Trial Data

Clinical trials should include clear data sharing plans and protocols. Disclosure of trial oversight supports trust in transfusion interventions.

Duplicate Submission

Manuscripts must not be under consideration elsewhere. Authors should disclose any related submissions or prior publications to avoid redundancy across all submissions.

Peer Review Model

IJBT uses independent peer review with appropriate subject expertise. Reviewer identities are protected to encourage frank, constructive feedback.

Editors may decline manuscripts that are out of scope to protect reviewer time and focus on transfusion medicine submissions.

Reporting Accuracy

Authors should retain source data and provide documentation when requested. Accurate reporting supports clinical trust in transfusion practices and policies.

Failure to provide documentation may lead to editorial action or corrections and regulatory review concerns.